Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
OP-3136-101
Phase 1 other active
Quick answer
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors for Advanced or Metastatic Solid Tumors is a Phase 1 program (other) at Olema Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Olema Pharmaceuticals
- Indication
- Advanced or Metastatic Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active